Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines.
about
Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophagesKorean red ginseng slows depletion of CD4 T cells in human immunodeficiency virus type 1-infected patientsContribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionLatent reservoirs of HIV: obstacles to the eradication of virusThe immunological synapse: the gateway to the HIV reservoirRecent developments in human immunodeficiency virus-1 latency researchMulti-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque ControllersUnderstanding HIV latency: the road to an HIV cureERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaBIsoquinolinesulphonamide derivatives inhibit transcriptional elongation of human immunodeficiency virus type 1 RNA in a promyelocytic model of latencyA stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patientsHIV drug resistance mutations in proviral DNA from a community treatment programThe anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2Residual Viremia in Treated HIV+ IndividualsLysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activationModeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy.Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral ReservoirsPPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infectionEnvelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulationNaturally occurring compounds elicit HIV-1 replication in chronically infected promonocytic cells.Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy.Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA constructMacaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines.Surfactant protein D inhibits HIV-1 infection of target cells via interference with gp120-CD4 interaction and modulates pro-inflammatory cytokine production.Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples.HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.Rational design of drugs that induce human immunodeficiency virus replication.Cell line-dependent variability in HIV activation employing DNMT inhibitorsImpact of latently infected cells on strain archiving within HIV hosts.Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.Immune activation and HIV persistence: implications for curative approaches to HIV infection.Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1.HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways.
P2860
Q21135536-7B337784-7E75-4B9A-A2B1-CFE282FB913CQ24521463-21724592-A80C-4AE7-8C5C-2B43C163B604Q24550678-C9CF8DC4-4112-4C25-94FA-FD18EF4BB4DBQ24615570-64DD819B-0AE3-4712-A9D8-4CCAF975222FQ27002959-1264E361-F9E4-418D-9E8D-7A5FBDC53E3CQ27013114-E593F0AA-12B5-497F-8D57-FA98190DC572Q27312050-72C305D2-B254-45CA-858A-1D1B9516ED91Q28085296-E636034E-B850-407D-B17F-4B4E9EA12259Q28144441-4DBCB262-12DF-4E53-A830-7C4D316F6462Q28376959-0F84F773-C612-4A89-BF2A-3F7C9E921476Q28477926-158D8BF8-1419-45AF-B927-3E2249CDC93BQ28543156-2F758329-B474-4227-91CD-3EB72487BF5DQ28546013-F97208F6-5CED-4412-85A2-AE03DED61997Q28552126-1909B3B3-92FA-4C8F-AEC2-005B99F0EA01Q30845033-7F265E40-2620-484B-9FA4-B5B1092BBAEFQ33508788-0E377B1C-4778-4488-8E69-04A30B808184Q33510903-6EBB880D-C958-4910-B238-1AF6FBA8C10FQ33541775-26E3E687-6C81-4E41-8D1E-CD64044E46E6Q33613493-04FC771D-15CA-4DDE-8708-7796DC8258C6Q33628817-C33194A7-A99E-4726-9C90-95CD46E7B890Q33649801-22E4889D-C764-4694-8C06-7A1E77ABC77BQ33678299-21F87F80-6F90-428F-A92F-68FE356ABC09Q33806165-A3DF4001-885F-499D-B90C-A5F068CFD287Q33822538-BBD3F66D-E45C-414E-BD47-7E854D148AAAQ33840048-54E49026-2353-42B5-A7A9-7491CD4BC76AQ33849629-386FF84A-43B1-40E0-B79F-0ADEDBB45350Q33921367-C3F2C652-9EF9-463A-AC44-C4FCE6AFEC91Q33963592-389AB22A-01D7-47B3-8B6E-4C1C9A016940Q34097573-F351522C-3708-4337-91AA-F8AECA38540AQ34124009-8737AB6A-DE8E-4A52-97D8-28035D192175Q34132738-F2587D02-5671-49F1-9AB4-28FE3030D81FQ34145909-7378883F-D80B-498D-A5FD-170793F6250CQ34229958-087246D6-029D-436D-9A36-0DD27ABFB895Q34243934-6F4835D7-D768-473A-8B23-D59F54FB6B92Q34331710-C6D18182-65E4-4763-8D30-E071B5EC95FBQ34333195-259E1E7A-8807-4B7A-BD8E-A9E18EB52204Q34349201-DACC9556-45AD-43F4-8293-4624D4DF054AQ34351320-F1EF3E20-472C-46D0-9D03-C7140CE3EF71Q34397109-6FD89749-16D3-4A78-976F-9E940F834D8EQ34440467-6FA4F734-D199-4C34-8E25-50782F94CB13
P2860
Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Induction of HIV-1 replication ...... ng a combination of cytokines.
@en
type
label
Induction of HIV-1 replication ...... ng a combination of cytokines.
@en
prefLabel
Induction of HIV-1 replication ...... ng a combination of cytokines.
@en
P2093
P2860
P356
P1476
Induction of HIV-1 replication ...... ng a combination of cytokines.
@en
P2093
P2860
P356
10.1084/JEM.188.1.83
P407
P577
1998-07-01T00:00:00Z